Katy Cooper

9PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesEpidemiological modellingMolecular targetsCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 11, 2025
Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation.

Paul Tappenden, Katy Cooper, Jean Hamilton

|Sep 27, 2025
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral in primary care. A systematic review, meta-analysis and cost-effectiveness analysis.

Sue Harnan, Aline Navega Biz, Jean Hamilton

|Aug 27, 2024
Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy.

Katy Cooper, Gamze Nalbant, Anthea Sutton

|Jul 25, 2024
Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy.

Katy Cooper, Gamze Nalbant, Anthea Sutton

|Jun 14, 2022
The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model.

Benjamin Kearns, Katy Cooper, Martin Orr

|Jan 06, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

Peter Murphy, David Glynn, Sofia Dias

Pageof 2

Frequent Collaborators

4 joint publications

Paul Tappenden

3 joint publications

Alice Bessey

3 joint publications

Anna Cantrell

2 joint publications

Sue Harnan